BioSpace News Archive

According to Healthy People 2020, America’s poorest children suffer high tooth decay rates, double that of non-poor children.

Government of Canada officials will hold a media availability to provide information on a novel coronavirus in Canada.

Medac, a leading provider of anesthesia revenue cycle management, today announced the successful completion of its fourth consecutive SOC 2 Type 2 examination and HIPAA risk assessment.

Today, BioTalent Canada and BioNova announced the launch of The PetriDish™ BioNova job board – giving companies in one of Canada’s fastest growing bio-economy hubs a platform to attract highly-skilled talent.

Foot Levelers, the world’s leader in custom-made orthotics, has introduced the latest version of its innovative Kiosk, launching the new technology at Parker Seminars Vegas.

Comar, a specialty packaging, device, and component supplier serving the Medical, Pharmaceutical, Consumer Healthcare, Personal and Home Care, Food and Beverage, and other niche market segments is building a custom facility in Rancho Cucamonga, CA.

Seurat Therapeutics, Inc. (Seurat) announced today the publication of preclinical studies of its lead product candidate, intranasal insulin-like growth factor-1 (IGF-1), in a rat model of migraine headaches, in the scientific journal Brain Research.

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to coronavirus relief efforts across the globe.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today sales of its screening test designed to identify the presence of the novel coronavirus that originated in China before spreading across the world over the past month

Can-Fite BioPharma Ltd.(NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced the pricing of a public offering of 3,333,334 units at a price to the public of $1.50 per unit.